ADALIMUMAB-BWWD vs ADALIMUMAB-RYVK

I just had a follow up with my gastrointerologist and the majority of our conversation was about all or most insurances not covering Abbvie’s Humira. He told me Abbie has been preparing to stop servicing Humira for a few years now and with the patent expiring, this is the year they have done it.

First, I would just love to say that I am so excited I found this. Newer to Reddit. But the amount of information that I have read in this has helped me tremendously. I was diagnosed a year and a half ago. Been through methotrexate and prednisone and unfortunately, I have been in a flareup for most

I just wanted to share my recent experience with recapturing remisson if it helps. I had been in Hadlima induced remission for 11 months and experienced the worst flare of my life the week before I started my new job. I was bed bound three full days and continued to suffer an additional three week

Hi all, I have been taking Humira auto-injector pen for Chron's and hidradentritis supprativa for several years now. i have had almost no issues. January this year, I received a letter that my insurance no longer covers Humira. my doctor said they would submit a prior authorization for me to try

Hello everyone. I was diagnosed almost a year ago. my flair ups have been reduced thanks to Hadlima, but I still experience frequent flair ups. I have a mostly desk job but I find myself in such incredible paid from looking down at paperwork I sometimes have to leave mid day. I was recently contacte

Just an informative post for those in Canada, but more specifically Ontario. My dermatologist, when I first met with her regarding HS, put me on an oral antibiotic (Amoxycilin) and a topical (clindamycin). Personally, the topical did not work for me, but after a few months, she recommended I try a

I'm an ex-junkie (8 years clean this past december) and I started hadlima a few months ago and I swear to God, for like 2-3 days after I take my shot, I feel vaguely like I'm going through withdrawal like sweaty, a little manic, jittery, rapid temperature shifts, and just like my whole body feels of

I’m a 49M Crohn’s veteran, pretty new to Reddit. I’ve been on Humira for the past 10 years with fantastic results. By far the longest remission period since I was diagnosed in 1986. Last summer I had a skin cancer spot on my ear, a basal cell. Had it removed via Moh’s surgery. Now I have another spo

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Lt

SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® PARSIPPANY, N.J. & REYKJAVÍK, Iceland--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced t

* In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI * SELARSDI is the second biosimilar to launch in the U.S. under t

February 23, 2024 8:15 PM SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership between Alvotech and Teva in the U.S. market SIMLANDI will qualify for intercha

Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S. commercialization agreement with Teva Pharmaceuticals The high-concentration interchangeable biosimilar to Hum

* Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis * The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection i